Kati Frid

595 total citations
16 papers, 320 citations indexed

About

Kati Frid is a scholar working on Molecular Biology, Nutrition and Dietetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kati Frid has authored 16 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Nutrition and Dietetics and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kati Frid's work include Prion Diseases and Protein Misfolding (10 papers), Pomegranate: compositions and health benefits (5 papers) and Neurological diseases and metabolism (4 papers). Kati Frid is often cited by papers focused on Prion Diseases and Protein Misfolding (10 papers), Pomegranate: compositions and health benefits (5 papers) and Neurological diseases and metabolism (4 papers). Kati Frid collaborates with scholars based in Israel. Kati Frid's co-authors include Ruth Gabizon, Orli Binyamin, Yael Friedman‐Levi, Tamir Ben‐Hur, Shlomo Magdassi, Liraz Larush, Haim Ovadia, Nina Fainstein, Ofira Einstein and Oded Abramsky and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Kati Frid

15 papers receiving 316 citations

Peers

Countries citing papers authored by Kati Frid

Since Specialization

Citations

This map shows the geographic impact of Kati Frid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kati Frid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kati Frid more than expected).

Fields of papers citing papers by Kati Frid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kati Frid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kati Frid. The network helps show where Kati Frid may publish in the future.

Co-authorship network of co-authors of Kati Frid

This figure shows the co-authorship network connecting the top 25 collaborators of Kati Frid. A scholar is included among the top collaborators of Kati Frid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kati Frid. Kati Frid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis 2024 ·Journal of Neuroimmunology ·Kati Frid, (unknown), (unknown), Orli Binyamin, (unknown), Ibrahim Kassis, (unknown), Ruth Gabizon	0
2	Nano-PSO Administration Attenuates Cognitive and Neuronal Deficits Resulting from Traumatic Brain Injury 2022 ·Molecules ·(unknown), Kati Frid, (unknown), Vardit Rubovitch, Ruth Gabizon, Chaim G. Pick	8
3	Comparing anti–aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob Disease 2021 ·Neurobiology of Aging ·Orli Binyamin, Kati Frid, (unknown), Ann Saada, Ruth Gabizon	6
4	Delay of gCJD aggravation in sick TgMHu2ME199K mice by combining NPC transplantation and Nano-PSO administration 2020 ·Neurobiology of Aging ·Kati Frid, Orli Binyamin, (unknown), Ruth Gabizon	6
5	Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice 2019 ·Scientific Reports ·Orli Binyamin, (unknown), Kati Frid, (unknown), Hanna Rosenmann, Ruth Gabizon	27
6	Autologous neural progenitor cell transplantation into newborn mice modeling for E200K genetic prion disease delays disease progression 2018 ·Neurobiology of Aging ·Kati Frid, Orli Binyamin, Nina Fainstein, (unknown), Tamir Ben‐Hur, Ruth Gabizon	11
7	Mitochondrial dysfunction in preclinical genetic prion disease: A target for preventive treatment? 2018 ·Neurobiology of Disease ·(unknown), Orli Binyamin, Kati Frid, Ann Saada, Ruth Gabizon	19
8	Continues administration of Nano-PSO significantly increased survival of genetic CJD mice 2017 ·Neurobiology of Disease ·Orli Binyamin, (unknown), Kati Frid, Liraz Larush, Shlomo Magdassi, Ruth Gabizon	16
9	Chronic Progressive Neurodegeneration in a Transgenic Mouse Model of Prion Disease 2016 ·Frontiers in Neuroscience ·Nina Fainstein, (unknown), Kati Frid, (unknown), (unknown), Ruth Gabizon, Tamir Ben‐Hur	11
10	Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant 2015 ·International Journal of Nanomedicine ·Ruth Gabizon, Orli Binyamin, Liraz Larush, Kati Frid, (unknown), Yael Friedman‐Levi, Haim Ovadia, Oded Abramsky, Shlomo Magdassi	52
11	Aggregation of MBP in chronic demyelination 2015 ·Annals of Clinical and Translational Neurology ·Kati Frid, Ofira Einstein, Yael Friedman‐Levi, Orli Binyamin, Tamir Ben‐Hur, Ruth Gabizon	43
12	Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD 2014 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Yael Friedman‐Levi, Liraz Larush, Kati Frid, Orli Binyamin, (unknown), Nina Fainstein, Haim Ovadia, Tamir Ben‐Hur, Shlomo Magdassi, Ruth Gabizon	79
13	Genetic prion disease: no role for the immune system in disease pathogenesis? 2014 ·Human Molecular Genetics ·Yael Friedman‐Levi, Orli Binyamin, Kati Frid, Haim Ovadia, Ruth Gabizon	1
14	Novel Pomegranate Oil Nano-Emulsions for the Prevention and Treatment of Neurodegenerative Diseases: The Case of Genetic CJD (P5.236) 2014 ·Neurology ·Ruth Gabizon, (unknown), (unknown), Liraz Larush, Kati Frid, Orli Binyamin, (unknown), (unknown), Haim Ovadia, Tamir Ben‐Hur, Shlomo Magdassi	1
15	Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression 2013 ·PLoS ONE ·Eran Cohen, Dana Avrahami, Kati Frid, Tamar Canello, Ephrat Levy‐Lahad, Sharon Zeligson, (unknown), Joab Chapman, Oren S. Cohen, Esther Kahana, Iris Lavon, Ruth Gabizon	16
16	Copper is toxic to PrP-ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease 2011 ·Neurobiology of Disease ·Tamar Canello, Yael Friedman‐Levi, (unknown), Orli Binyamin, Eran Cohen, Kati Frid, Ruth Gabizon	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact